C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 233/64 (2006.01) A61K 31/4164 (2006.01) A61K 31/4178 (2006.01) A61K 31/5375 (2006.01) A61K 31/553 (2006.01) C07D 401/12 (2006.01) C07D 403/12 (2006.01) C07D 405/04 (2006.01) C07D 405/12 (2006.01) C07D 417/12 (2006.01) C07D 498/04 (2006.01)
Patent
CA 2722159
Presently provided are compounds according to the formula (I) or (II), and pharmaceutical compositions compris-ing the compounds, wherein R1, R4, and R5 are defined herein. Such compounds and compositions are useful for modulating an activity of indoleamine 2,3-dioxygenase; treating indoleamine 2,3-dioxygenase (IDO) mediated immunosuppression; treating a medical conditions that benefit from the inhibition of enzymatic activity of indoleamine -2,3-dioxygenase; enhancing the effec-tiveness of an anti- cancer treatment comprising administering an anti-cancer agent; treating tumor-specific immmosuppression associated with cancer; and treating immunosupression associated with an infectious disease.
Linvention concerne des composés selon la formule (I) ou (II), et des compositions pharmaceutiques comprenant les composés, où R1, R4 et R5 sont définis ici. De tels composés et compositions sont utiles pour la modulation dune activité de lindoleamine 2,3-dioxygénase; le traitement de limmunosuppression véhiculée par lindoleamine 2,3-dioxygénase; le traitement daffections médicales qui bénéficient de linhibition de lactivité enzymatique de lindoleamine 2,3-dioxygénase; lamélioration de lefficacité dun traitement anticancéreux comprenant ladministration dun agent anticancéreux; le traitement de limmunosuppression spécifique de tumeur associée au cancer; et le traitement de limmunosuppression associée à une maladie infectieuse.
Jaipuri Firoz
Kesharwani Tanay
Kumar Sanjeev
Lalonde Judith
Link Charles J.
Lankenau Institute For Medical Research
Mbm Intellectual Property Law Llp
Newlink Genetics Corporation
LandOfFree
Ido inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ido inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ido inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1398401